Related Experiment Video
Updated: Jan 20, 2026
10:10
Reverse Total Shoulder Arthroplasty
Published on: July 5, 2011
43.8K
[Arthroplasty in patients with osteoporosis]
Carl Haasper1, Mustafa Citak2, Max Ettinger3
1Orthopädie, Unfallchirurgie und Ästhetik, AMEOS Klinikum Seepark, Langener Str. 66, 27607, Geestland, Deutschland. chaa.ortho@geestland.ameos.de.
Der Unfallchirurg
|August 21, 2019
Summary
Cemented arthroplasty is recommended for patients with osteoporosis undergoing knee or hip replacement. Early mobilization and loading may also benefit osteoporosis treatment.
Area of Science:
- Orthopedic surgery
- Bone metabolism
Background:
- Arthroplasty demonstrates excellent long-term success.
- Osteoporosis management in arthroplasty patients requires specific considerations.
Purpose of the Study:
- To evaluate current recommendations for osteoporosis screening and treatment in arthroplasty.
- To determine optimal cementing and fixation strategies for arthroplasty in osteoporotic patients.
Main Methods:
- Review of current literature and clinical guidelines regarding osteoporosis and arthroplasty.
- Analysis of outcomes for cemented versus cement-free arthroplasty in osteoporotic bone.
Main Results:
- Pre-operative osteoporosis screening and pharmacologic treatment are not routinely recommended.
- Cemented knee arthroplasty is advised for patients with known osteoporosis.
- Cemented hip joint replacement, including acetabular components, is also recommended despite good cement-free outcomes.
Conclusions:
- Cemented fixation is the preferred method for knee and hip arthroplasty in patients with osteoporosis.
- Early weight-bearing and mobilization are beneficial for both arthroplasty outcomes and systemic osteoporosis management.
More Related Videos
Related Concept Videos
01:13Patient-centered Care
2.9K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.9K
01:21Drug Dosing: Obese Patients
232
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
232
01:15Drug Dosing: Geriatric Patients
229
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
229
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
261
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
261
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
196
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
191
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
191